The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study
Open accessAbstract
SUMMARY: The Women's Health Initiative (WHI) double-blind, placebo-controlled clinical trial randomly assigned 36,282 postmenopausal women in the U.S. to 1,000 mg elemental calcium carbonate plus 400 IU of vitamin D(3) daily or placebo, with average intervention period of 7.0 years. The trial was designed to test whether calcium plus vitamin D supplementation in a population in which the use of these supplements was widespread would reduce hip fracture, and secondarily, total fracture and colorectal cancer. INTRODUCTION: This study further examines the health benefits and risks of calcium and vitamin D supplementation using WHI data, with emphasis on fractures, cardiovascular disease, cancer, and total mortality. METHODS: WHI calcium and vitamin D randomized clinical trial (CT) data through the end of the intervention period were further analyzed with emphasis on treatment effects in relation to duration of supplementation, and these data were contrasted and combined with corresponding data from the WHI prospective observational study (OS). RESULTS: Among women not taking personal calcium or vitamin D supplements at baseline, the hazard ratio [HR] for hip fracture occurrence in the CT following 5 or more years of calcium and vitamin D supplementation versus placebo was 0.62 (95 % confidence interval (CI), 0.38-1.00). In combined analyses of CT and OS data, the corresponding HR was 0.65 (95 % CI, 0.44-0.98). Supplementation effects were not apparent on the risks of myocardial infarction, coronary heart disease, total heart disease, stroke, overall cardiovascular disease, colorectal cancer, or total mortality, while evidence for a reduction in breast cancer risk and total invasive cancer risk among calcium plus vitamin D users was only suggestive. CONCLUSION: Though based primarily on a subset analysis, long-term use of calcium and vitamin D appears to confer a reduction that may be substantial in the risk of hip fracture among postmenopausal women. Other health benefits and risks of supplementation at doses considered, including an elevation in urinary tract stone formation, appear to be modest and approximately balanced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intakes in excess of 1200 to 1500 mg/day may increase the risk of developing kidney stones, cardiovascular disease, and stroke.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883
Self-citationMeasurement Characteristics of the Women’s Health Initiative Food Frequency Questionnaire
Patterson, R. E., Kristal, A. R., Tinker, L. F., Carter, R. A., Bolton, M. P., & Agurs-Collins, T. (1999) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00055-6 · Cited by 1,025
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Wactawski-Wende, J., Kotchen, J. M., Anderson, G. L., Assaf, A. R., Brunner, R. L., O'Sullivan, M. J., Margolis, K. L., Ockene, J. K., Phillips, L., Pottern, L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055222 · Cited by 980 · cited 2×
“Additional analyses led to reports of no clear evidence of benefit or harm for colorectal cancer [2], breast cancer [3], or other invasive cancer [4], though the possibility of a breast cancer risk reduction among women using little or no personal calcium supplements was noted [3].”
BackgroundSelf-citationBolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851
Outcomes ascertainment and adjudication methods in the women's health initiative
Curb, J. D., Mctiernan, A., Heckbert, S. R., Kooperberg, C., Stanford, J., Nevitt, M., Johnson, K. C., Proulx-Burns, L., Pastore, L., Criqui, M., et al. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00048-6 · Cited by 698 · cited 1×
“Clinical outcomes were self-reported semiannually in the CT and annually in the OS [27].”
MethodCalcium/Vitamin D Supplementation and Cardiovascular Events
Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Heckbert, S. R., Johnson, K. C., Manson, J. E., Sidney, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.673491 · Cited by 662
Self-citationLanger, R. D., White, E., Lewis, C. E., Kotchen, J. M., Hendrix, S. L., & Trevisan, M. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00047-4 · Cited by 630 · cited 1×
“Baseline characteristics have been presented [26].”
Intake of Potassium, Magnesium, Calcium, and Fiber and Risk of Stroke Among US Men
Ascherio, A., Rimm, E. B., Hernán, M. A., Giovannucci, E. L., Kawachi, I., Stampfer, M. J., & Willett, W. C. (1998) · Circulation · doi:10.1161/01.cir.98.12.1198 · Cited by 451
Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer
Chlebowski, R. T., Johnson, K. C., Kooperberg, C., Pettinger, M., Wactawski-Wende, J., Rohan, T., Rossouw, J., Lane, D., O’Sullivan, M. J., Yasmeen, S., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn360 · Cited by 427
Self-citation
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
“The scientific literature is highly controversial in this area [31–34].”
BackgroundThe clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
“Increasing calcium intake beyond the recommended levels has not been shown to be useful and may be harmful (140-144).”
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
Bouillon, R., Marcocci, C., Carmeliet, G., Bikle, D., White, J. H., Dawson-Hughes, B., Lips, P., Munns, C. F., Lazaretti-Castro, M., Giustina, A., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00126 · Cited by 1,143
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Metadata
- Authors
- Prentice, R. L., Pettinger, M. B., Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Anderson, G. L., Chlebowski, R. T., Manson, J. E., Van Horn, L., Vitolins, M. Z., Datta, M., LeBlanc, E. S., Cauley, J. A., & Rossouw, J. E.
- Affiliations
- Fred Hutch Cancer Center (US)
- The Ohio State University (US)
- The Lundquist Institute (US)
- Brigham and Women's Hospital (US)
- Wake Forest University Health Sciences (US)
- Kaiser Permanente Center for Health Research (US)
- University of Pittsburgh (US)
- National Institutes of Health (US)
- Corresponding author
- Prentice, R. L.
- ORCID
- Venue
- Osteoporosis International
- Published
- 2012-12-04
- Volume
- 24
- Issue
- 2
- Pages
- 567-580
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- PMC
- PMC3557387
- OpenAlex
- W2009142498
- Cited by
- 295
- References
- 31
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 17 · 2023: 9 · 2022: 16 · 2021: 18 · 2020: 29 · 2019: 21 · 2018: 25 · 2017: 19 · 2016: 34 · 2015: 35 · 2014: 32 · 2013: 30
- FWCI
- 22.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Osteoporosis International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
- National University of Singapore (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services (42129‐32, 42107-26, 32108‐9, 32118-32119, 32115, 32111‐13, 32100‐2, 44221, 32105‐6, 32122, 24152, N01-WH-2-2110)
- Brigham and Women's Hospital
- Ohio State University
- Wake Forest University
- University of Pittsburgh
- MedStar Health Research Institute
- National Institutes of Health (n01wh42124-20-0-0, n01wh42120-22-0-1, N01-WH-4-2107, n01wh42125-19-0-1, n01wh042116-008, n01wh32112-26-0-1, N01-WH-4-2122, N01-WH-3-2109, n01wh42130-23-0-1, n01wh42123-22-0-1, n01wh42108-21-0-1, N01-WH-3-2111, n01wh042114-008, n01wh32118-27-0-1, N01-WH-3-2119, 32122, n01wh42110-25-0-0, 32111‐13, n01wh42122-22-0-1, N01-WH-4-2126, 32108‐9, 42129‐32, N01-WH-4-2111, N01-WH-4-2129, n01wh42131-22-0-1, N01-WH-4-2130, n01wh44221-7-0-1, N01-WH-3-2118, 42107–26, n01wh42129-23-0-1, N01-WH-4-2116, N01-WH-4-2110, n01wh42115-19-0-1, n01wh32111-28-0-1, n01wh32115-26-0-1, N01 WH 44221, n01wh22110-38-0-0, N01-WH-3-2115, N01-WH-4-2117, 32118-32119, n01wh42132-22-0-1, 44221, n01wh42121-21-0-1, 32115, n01wh42111-19-0-1, 32100‐2, N01-WH-4-2124, n01wh42113-23-0-1, N01-WH-4-2131, n01wh32113-30-0-1, N01-WH-4-2113, n01wh42119-25-0-1, N01-WH-4-2109, N01-WH-4-2115, N01-WH-4-2132, N01-WH-3-2112, N01-WH-4-2121, n01wh42126-26-0-1, n01wh32122-31-0-1, n01wh42118-20-0-1, N01-WH-4-2119, n01wh32119-24-0-1, N01-WH-3-2122, n01wh42107-22-0-1, N01-WH-4-2125, n01wh42109-28-0-1, n01wh042112-013, N01-WH-4-2120, N01-WH-2-2110, N01-WH-4-2114, n01wh42117-21-0-1, N01-WH-4-2123, N01-WH-4-2118, 24152, N01-WH-4-2112, N01-WH-4-2108, N01 WH022110, CA53996, n01wh32109-27-0-1, N01-WH-3-2113, 32105-6)
- U.S. Public Health Service (32101, 32100, 24152, 32105, 32102, 32108)
- University at Buffalo
- National Heart, Lung, and Blood Institute (32100‐2, 32118‐32119, N01‐WH‐22110, N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 32118, 42107‐26, 32119, 24152, and 44221, 32105–6, 32108‐9, 32111–13, 32115, 42129‐32, 32122, 44221)
- National Cancer Institute (CA53996, R25CA122061, P01CA053996, R01CA119171)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- calcium supplementation, vitamin D supplementation, postmenopausal women, hip fracture, fracture risk, cardiovascular disease, colorectal cancer, breast cancer, all-cause mortality, urolithiasis, duration of supplementation, Women's Health Initiative
- MeSH terms
- Aged, Calcium Carbonate, Cardiovascular Diseases, Cholecalciferol, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Female, Hip Fractures, Humans, Middle Aged, Neoplasms, United States, Urinary Calculi, Osteoporosis, Postmenopausal, Risk Assessment, Dietary Supplements, Bone Density Conservation Agents, Osteoporotic Fractures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. https://app.cochat.ai/papers/10.1007/s00198-012-2224-2
- The paper
- Prentice, R. L., Pettinger, M. B., Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Anderson, G. L., Chlebowski, R. T., Manson, J. E., Van Horn, L., Vitolins, M. Z., Datta, M., LeBlanc, E. S., Cauley, J. A., & Rossouw, J. E. (2013). Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporosis International. https://doi.org/10.1007/s00198-012-2224-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.